封面
市場調查報告書
商品編碼
1425001

疾病控制和預防疫苗市場,按產品類型、給藥途徑、適應症、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Disease Control And Prevention Vaccine Market, By Product Type, By Route of administration, By Indication, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日期: | 出版商: AnalystView Market Insights | 英文 265 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2023年疾病管制與預防疫苗市場規模為512.103億美元,2024年至2032年複合CAGR為10.5%。

疾管疫苗市場-市場動態

全球傳染病發病率的上升和疫苗的採用預計將推動疾病控制和預防疫苗市場的擴大。

全球傳染病發生率呈上升趨勢,疫苗的使用有望在控制和預防其傳播方面發揮重要作用。疫苗對於保障公眾健康非常重要,隨著人們對其重要性的認知不斷提高,全世界擴大採用疫苗接種計劃。政府、醫療機構和個人認知到疫苗在保護社區免受傳染病負擔方面的價值。縱觀歷史,傳染病給人們帶來了巨大的痛苦,無論是疾病或死亡。根據疾病管制與預防中心的資料,有 1,020 萬人次因傳染病和寄生蟲病就診,有 380 萬人次以這些疾病為初步診斷而去急診室就診。疫苗技術的持續研究和開發為市場成長帶來了光明的前景。然而,值得注意的是,嚴格的監管程序可能會對疾病管制和預防疫苗市場的擴張構成挑戰。

疾病管制與預防疫苗市場-關鍵見解

根據研究分析師的分析,預計全球市場在預測期內(2024-2032年)每年將以 10.5%左右的CAGR成長

根據產品類型細分,預計減毒活疫苗將在2023年佔據最大市場佔有率

根據給藥途徑細分,注射劑是2023年的主導類型

依適應症細分,2023年傳染病為主導類型

依地區分類,北美是2023年的主要收入來源

疾病管制與預防疫苗市場-細分分析:

全球疾病控制和預防疫苗市場根據產品類型、給藥途徑、適應症和地區進行細分。

市場依產品類型分為四大類:減毒活疫苗、去活化疫苗、重組疫苗和類毒素疫苗。減毒活疫苗佔據了市場的很大一部分。這些疫苗以其卓越的有效性而聞名,它們非常模仿自然感染,提供強大而持久的免疫力。

根據給藥途徑,市場分為兩類:口服和注射。注射劑市場佔據了很大一部分市場。注射疫苗透過注射(通常是肌肉注射(IM)或皮下注射(SC))來刺激免疫系統並引發免疫反應。

市場依適應症分為兩類:傳染病、癌症和其他適應症。傳染病領域對市場有重大影響力。許多國家實施免疫計劃來控制傳染病的傳播。這些計劃通常包括常規兒童疫苗接種和針對特定族群的針對性疫苗接種。

疾病管制與預防疫苗市場-地理洞察

從地理來看,該市場遍佈北美、拉丁美洲、歐洲、亞太、中東和非洲等多個地區。這些區域根據參與商業活動的國家進一步分類。在預測期內,市場成長預計將由北美推動,這主要是由於高度先進技術的可用性和創新疫苗的持續開發。北美,尤其是美國,以其先進的醫療基礎設施和研究能力而聞名。該地區擁有眾多製藥和生物技術公司,這些公司大力投資研發,開發了疫苗生產的尖端技術。2022年底,美國預計將在醫療保健方面支出4.5兆美元,成為全球醫療保健整體支出最高的國家。根據美國醫療保健最新資料和報告,2021年該國總體支出預計將達到4.3兆美元,佔GDP的18.5%。歐洲是預測期內市場成長的第二大地區,這主要是由於疾病負擔的增加。

疾病管制與預防疫苗市場-競爭格局:

疾病管制與預防疫苗市場涵蓋各種組織和公司開發的各種用於對抗不同疾病的疫苗。疫苗進步的顯著貢獻者包括世界衛生組織(WHO)、美國國立衛生研究院(NIH)和私人實體。最近出現的傳染病規模空前,為疫苗開發商、監管機構、衛生當局和政治選民帶來了新的挑戰。疫苗的生產和分銷是一個複雜的過程,需要快速並仔細考慮臨床開發、緊急使用授權、疫苗安全監測和病毒變種監測。優先考慮低收入和中等收入國家的疫苗取得和疫苗接種工作非常重要。雖然疫苗行業與製藥行業相比規模較小,但穩步成長。疫苗產業內的公司從事疫苗的研究、開發、製造、銷售、行銷和分銷,其收入主要來自疫苗產品銷售。

最新進展:

據輝瑞公司表示,2023年10月,FDA 批准了PENBRAYA(腦膜炎球菌A、B、C、W 和Y 群疫苗)。這是第一個也是唯一一個五價疫苗,可以預防引起青少年和年輕人(10-25 歲)腦膜炎雙球菌疾病最常見的血清群。為了幫助預防導致全球大多數侵襲性腦膜炎球菌疾病(IMD)的五種最常見腦膜炎雙球菌血清群,PENBRAYA 結合了兩種腦膜炎雙球菌疫苗的成分:Nimenrix(R)(腦膜炎雙球菌群A、 C、W-135 和Y 結合疫苗)和 Trumenba(R)(B 型腦膜炎雙球菌疫苗)。

目錄

第1章 疾病管制與預防疫苗市場概述

  • 研究範圍
  • 市場預估年份

第2章 執行摘要

  • 市場摘要
    • 依產品類型分類的疾病管制與預防疫苗市場摘要
    • 依給藥途徑分類的疾病管制與預防疫苗市場摘要
    • 依適應症分類的疾病管制與預防疫苗市場摘要
    • 依國家分類的疾病管制與預防疫苗市場摘要
    • 依地區分類的疾病管制與預防疫苗市場摘要
  • 競爭洞察

第3章 疾病管制與預防疫苗主要市場趨勢

  • 疾病管制與預防疫苗市場促進因素
    • 市場促進因素的影響分析
  • 疾病管制與預防疫苗市場限制
    • 市場限制影響分析
  • 疾病管制與預防疫苗市場機會
  • 疾病預防控制疫苗市場未來趨勢

第4章 疾病預防控制疫苗產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第5章 疾病管制與預防疫苗市場:COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第6章 疾病管制與預防疫苗市場格局

  • 2023年疾病管制與預防疫苗市場佔有率分析
  • 細分資料:按主要製造商
    • 既有參與者分析
    • 新興參與者分析

第7章 疾病管制與預防疫苗市場 - 依產品類型

  • 概述
    • 依產品類型分類的細分市場佔有率分析
    • 減毒活疫苗
    • 去活化疫苗
    • 重組疫苗
    • 類毒素疫苗

第8章 疾病管制與預防疫苗市場 - 依給藥途徑

  • 概述
    • 依給藥途徑分類的細分市佔率分析
    • 口服
    • 注射

第9章 疾病管制與預防疫苗市場 - 按適應症

  • 概述
    • 按適應症分類的細分市場佔有率分析
    • 傳染病
    • 癌症
    • 其他適應症

第10章 疾病管制與預防疫苗市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美疾病管制與預防疫苗主要製造商
    • 北美市場規模和預測(依國家)
    • 北美市場規模和預測(依產品類型)
    • 北美市場規模與預測(依給藥途徑)
    • 北美市場規模和預測(按適應症)
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲疾病管制與預防疫苗主要製造商
    • 歐洲市場規模和預測(依國家)
    • 歐洲市場規模和預測(依產品類型)
    • 歐洲市場規模與預測(依給藥途徑)
    • 歐洲市場規模與預測(按適應症)
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區(APAC)
    • 概述
    • 亞太地區疾病管制與預防疫苗主要製造商
    • 亞太地區市場規模與預測(依國家)
    • 亞太地區市場規模與預測(依產品類型)
    • 亞太地區市場規模與預測(依給藥途徑)
    • 亞太地區市場規模與預測(按適應症)
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲疾病管制與預防疫苗主要製造商
    • 拉丁美洲市場規模與預測(依國家)
    • 拉丁美洲市場規模與預測(依產品類型)
    • 拉丁美洲市場規模與預測(依給藥途徑)
    • 拉丁美洲市場規模與預測(按適應症)
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲疾管疫苗主要生產商
    • 中東和非洲市場規模及預測(依國家)
    • 中東和非洲市場規模及預測(依產品類型)
    • 中東和非洲市場規模和預測(依給藥途徑)
    • 中東和非洲市場規模及預測(按適應症)
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA的其他地區

第11章 疾病預防疫苗產業主要供應商分析

  • 競爭儀表板
  • 公司簡介
    • Merck & Co. GlaxoSmithKline plc.
    • Sanofi, AstraZeneca PLC
    • Pfizer Inc.
    • Astellas Pharma Inc.
    • Sinovac Biotech Ltd.
    • Daiichi Sankyo
    • Serum Institute of India Pvt. Ltd.

第12章 360 度分析師視角

第13章 附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV2201

REPORT HIGHLIGHT

Disease Control And Prevention Vaccine Market size was valued at USD 51,210.3 Million in 2023, expanding at a CAGR of 10.5% from 2024 to 2032.

Immunization is widely recognized as a significant achievement in public health throughout the twentieth century. Vaccines have proven to be highly effective in preventing diseases, saving lives, and reducing healthcare costs. The widespread adoption of vaccination has successfully prevented disability and death in numerous children, leading governments worldwide to prioritize vaccination in their public health services. China, for instance, has effectively controlled infectious diseases through its national immunization program, which is based on vaccination. The Centers for Disease Control and Prevention (CDC) plays a crucial role in recommending and promoting vaccination programs to protect individuals and communities from vaccine-preventable diseases. The CDC provides vaccination guidelines, monitors vaccine safety, conducts research on vaccine effectiveness, and collaborates with other organizations to ensure a comprehensive approach to disease prevention.

Disease Control And Prevention Vaccine Market- Market Dynamics

Rising incidence of infectious diseases worldwide and the adoption of vaccines are anticipated to propel the expansion of the Disease Control and Prevention Vaccine market.

The global incidence of infectious diseases is on the rise, and the use of vaccines is expected to play a significant role in controlling and preventing their spread. Vaccines are crucial in safeguarding public health, and as awareness about their importance increases, there is a growing adoption of vaccination programs worldwide. Governments, healthcare organizations, and individuals are recognizing the value of vaccines in protecting communities from the burden of infectious diseases. Throughout history, infectious diseases have caused immense suffering, both in terms of illness and death. According to the Center for Disease Control and Prevention, there were 10.2 million visits to physician offices for infectious and parasitic diseases, and 3.8 million emergency department visits with these diseases as the primary diagnosis. Ongoing research and development in vaccine technology hold promising prospects for market growth. However, it is important to note that stringent regulatory processes may pose challenges to the expansion of the Disease Control and Prevention Vaccine market.

Disease Control And Prevention Vaccine Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 10.5% over the forecast period (2024-2032)

Based on product type segmentation, Live-attenuated Vaccines was predicted to show maximum market share in the year 2023

Based on Route of administration segmentation, Injectable was the leading type in 2023

Based on Indication segmentation, Infectious Disease was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Disease Control And Prevention Vaccine Market- Segmentation Analysis:

The Global Disease Control And Prevention Vaccine Market is segmented on the basis of Product Type, Route of administration, Indication, and Region.

The market is divided into four categories based on product type: Live-attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines and Toxoid Vaccines. Live-attenuated vaccines dominate a substantial portion of the market. Renowned for their remarkable effectiveness, these vaccines closely mimic natural infections, providing robust and long-lasting immunity.

The market is divided into two categories based on Route of administration: Oral and Injectable. The injectable segment commands a substantial portion of the market. Injectable vaccines are delivered through injections, typically either intramuscularly (IM) or subcutaneously (SC), to stimulate the immune system and initiate an immune response.

The market is divided into two categories based on Indication: Infectious Disease, Cancer and Other Indication. The Infectious Disease segment holds significant sway over the market. Many nations implement immunization programs to control the spread of infectious diseases. These programs often include routine childhood vaccinations and targeted vaccinations for specific populations.

Disease Control And Prevention Vaccine Market- Geographical Insights

Geographically, this market is spread across various regions including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided based on the countries involved in business activities. The market growth is expected to be driven by North America in the forecast period, primarily due to the availability of highly advanced technologies and the increasing development of innovative vaccines. North America, especially the United States, is renowned for its advanced healthcare infrastructure and research capabilities. The region is home to numerous pharmaceutical and biotechnology companies that heavily invest in research and development, leading to the development of cutting-edge technologies for vaccine production. By the end of 2022, the United States is projected to spend USD 4.5 trillion on healthcare, making it the country with the highest overall healthcare expenditure globally. According to the latest data and reports on healthcare in the United States, the country's overall spending in 2021 is estimated to reach USD 4.3 trillion, accounting for 18.5% of its GDP. Europe holds the second-largest region for market growth during the forecast period, primarily due to the increasing disease burden.

Disease Control And Prevention Vaccine Market- Competitive Landscape:

The Disease Control and Prevention Vaccine market encompasses a wide range of vaccines developed by various organizations and companies to combat different diseases. Notable contributors to vaccine advancements include the World Health Organization (WHO), National Institutes of Health (NIH), and private entities. The recent emergence of infectious diseases on an unprecedented scale has presented new challenges for vaccine developers, regulators, health authorities, and political constituencies. The manufacturing and distribution of vaccines are complex processes that require both speed and careful consideration of clinical development, emergency use authorization, vaccine safety monitoring, and surveillance of virus variants. It is crucial to prioritize access to vaccines and vaccination efforts in low- and middle-income countries. While the vaccine industry is smaller compared to the pharmaceutical industry, it is steadily growing. Companies within the vaccine industry engage in research, development, manufacturing, sales, marketing, and distribution of vaccines, with their revenue primarily derived from vaccine product sales.

Recent Development:

In October 2023, the FDA has approved PENBRAYA (meningococcal groups A, B, C, W, and Y vaccine), according to Pfizer Inc. This is the first and only pentavalent vaccine that protects against the most common serogroups that cause meningococcal disease in adolescents and young adults (10-25 years of age). In order to help protect against the five most common meningococcal serogroups that cause the majority of invasive meningococcal disease (IMD) worldwide, PENBRAYA combines the components from two meningococcal vaccines: Nimenrix® (meningococcal groups A, C, W-135, and Y conjugate vaccine) and Trumenba® (meningococcal group B vaccine).

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL DISEASE CONTROL AND PREVENTION VACCINE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Merck & Co. GlaxoSmithKline plc.

Sanofi, AstraZeneca PLC

Pfizer Inc.

Astellas Pharma Inc.

Sinovac Biotech Ltd.

Daiichi Sankyo

Serum Institute of India Pvt. Ltd.

GLOBAL DISEASE CONTROL AND PREVENTION VACCINE MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Live-attenuated Vaccines
  • Inactivated Vaccines
  • Recombinant Vaccines
  • Toxoid Vaccines

GLOBAL DISEASE CONTROL AND PREVENTION VACCINE MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032

  • Oral
  • Injectable

GLOBAL DISEASE CONTROL AND PREVENTION VACCINE MARKET, BY INDICATION- MARKET ANALYSIS, 2019 - 2032

  • Infectious Disease
  • Cancer
  • Other Indication

GLOBAL DISEASE CONTROL AND PREVENTION VACCINE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Disease Control And Prevention Vaccine Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Disease Control And Prevention Vaccine Market Snippet by Product Type
    • 2.1.2. Disease Control And Prevention Vaccine Market Snippet by Route of administration
    • 2.1.3. Disease Control And Prevention Vaccine Market Snippet by Indication
    • 2.1.4. Disease Control And Prevention Vaccine Market Snippet by Country
    • 2.1.5. Disease Control And Prevention Vaccine Market Snippet by Region
  • 2.2. Competitive Insights

3. Disease Control And Prevention Vaccine Key Market Trends

  • 3.1. Disease Control And Prevention Vaccine Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Disease Control And Prevention Vaccine Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Disease Control And Prevention Vaccine Market Opportunities
  • 3.4. Disease Control And Prevention Vaccine Market Future Trends

4. Disease Control And Prevention Vaccine Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Disease Control And Prevention Vaccine Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Disease Control And Prevention Vaccine Market Landscape

  • 6.1. Disease Control And Prevention Vaccine Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Disease Control And Prevention Vaccine Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2. Live-attenuated Vaccines
    • 7.1.3. Inactivated Vaccines
    • 7.1.4. Recombinant Vaccines
    • 7.1.5. Toxoid Vaccines

8. Disease Control And Prevention Vaccine Market - By Route of administration

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Route of administration, 2023 & 2032 (%)
    • 8.1.2. Oral
    • 8.1.3. Injectable

9. Disease Control And Prevention Vaccine Market - By Indication

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Indication, 2023 & 2032 (%)
    • 9.1.2. Infectious Disease
    • 9.1.3. Cancer
    • 9.1.4. Other Indication

10. Disease Control And Prevention Vaccine Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Disease Control And Prevention Vaccine Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Disease Control And Prevention Vaccine Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Disease Control And Prevention Vaccine Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Disease Control And Prevention Vaccine Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Disease Control And Prevention Vaccine Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Disease Control And Prevention Vaccine Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Merck & Co. GlaxoSmithKline plc.
    • 11.2.2. Sanofi, AstraZeneca PLC
    • 11.2.3. Pfizer Inc.
    • 11.2.4. Astellas Pharma Inc.
    • 11.2.5. Sinovac Biotech Ltd.
    • 11.2.6. Daiichi Sankyo
    • 11.2.7. Serum Institute of India Pvt. Ltd.

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Disease Control And Prevention Vaccine Market: Product Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Disease Control And Prevention Vaccine Market, by Product Type 2019-2032 (USD Million)
  • TABLE Disease Control And Prevention Vaccine Market: Route of administration Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Route of administration
  • TABLE Global Disease Control And Prevention Vaccine Market, by Route of administration 2019-2032 (USD Million)
  • TABLE Disease Control And Prevention Vaccine Market: Indication Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Indication
  • TABLE Global Disease Control And Prevention Vaccine Market, by Indication 2019-2032 (USD Million)
  • TABLE Disease Control And Prevention Vaccine Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Disease Control And Prevention Vaccine Market, by Region 2019-2032 (USD Million)
  • TABLE North America Disease Control And Prevention Vaccine Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Disease Control And Prevention Vaccine Market, by Product Type, 2019-2032 (USD Million)
  • TABLE North America Disease Control And Prevention Vaccine Market, by Route of administration, 2019-2032 (USD Million)
  • TABLE North America Disease Control And Prevention Vaccine Market, by Indication, 2019-2032 (USD Million)
  • TABLE Europe Disease Control And Prevention Vaccine Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Disease Control And Prevention Vaccine Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Europe Disease Control And Prevention Vaccine Market, by Route of administration, 2019-2032 (USD Million)
  • TABLE Europe Disease Control And Prevention Vaccine Market, by Indication, 2019-2032 (USD Million)
  • TABLE Asia Pacific Disease Control And Prevention Vaccine Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Disease Control And Prevention Vaccine Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Disease Control And Prevention Vaccine Market, by Route of administration, 2019-2032 (USD Million)
  • TABLE Asia Pacific Disease Control And Prevention Vaccine Market, by Indication, 2019-2032 (USD Million)
  • TABLE Latin America Disease Control And Prevention Vaccine Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Disease Control And Prevention Vaccine Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Latin America Disease Control And Prevention Vaccine Market, by Route of administration, 2019-2032 (USD Million)
  • TABLE Latin America Disease Control And Prevention Vaccine Market, by Indication, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Disease Control And Prevention Vaccine Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Disease Control And Prevention Vaccine Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Disease Control And Prevention Vaccine Market, by Route of administration, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Disease Control And Prevention Vaccine Market, by Indication, 2019-2032 (USD Million)

List of Figures

  • FIGURE Disease Control And Prevention Vaccine Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Product Type segment market share analysis, 2023 & 2032
  • FIGURE Product Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Route of administration segment market share analysis, 2023 & 2032
  • FIGURE Route of administration segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indication segment market share analysis, 2023 & 2032
  • FIGURE Indication segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Disease Control And Prevention Vaccine Market share and leading players, 2023
  • FIGURE Europe Disease Control And Prevention Vaccine Market share and leading players, 2023
  • FIGURE Asia Pacific Disease Control And Prevention Vaccine Market share and leading players, 2023
  • FIGURE Latin America Disease Control And Prevention Vaccine Market share and leading players, 2023
  • FIGURE Middle East and Africa Disease Control And Prevention Vaccine Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Disease Control And Prevention Vaccine Market share analysis by country, 2023
  • FIGURE Germany Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Disease Control And Prevention Vaccine Market share analysis by country, 2023
  • FIGURE India Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Phillipines Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Disease Control And Prevention Vaccine Market share analysis by country, 2023
  • FIGURE Brazil Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Disease Control And Prevention Vaccine Market share analysis by country, 2023
  • FIGURE Saudi Arabia Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)